Tempus AI Doubles Down On Moderna and Merck Cancer Vaccine Infrastructure
Tempus AI expands its collaboration with Moderna and Merck to support sample collection and NGS services for intismeran autogene and Keytruda.
Stocks · News reference
On August 20, 2026, Personalis, Inc. received a new task order under its contract with the U.S. Department of Veterans Affairs (VA) for the VA's Million Veteran Program (VA MVP). The new task order is effective on
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Tempus AI expands its collaboration with Moderna and Merck to support sample collection and NGS services for intismeran autogene and Keytruda.
Filed: 2026-10-06 AccNo: 0001193125-26-415547 Size: 156 KB Item 8.01: Other Events
Analysts downgraded Gentex, Personalis, Goosehead Insurance, cutting ratings and several price targets.
BTIG analyst Mark Massaro downgrades Personalis (NASDAQ:PSNL) from Buy to Neutral.